The common class of drug that incites more overdoses when paired with an opioid is the benzodiazepine family. Often called ‘benzos,’ these drugs are prescribed to alleviate anxiety.
The study examined data collected from more than 71,000 Medicare Part D beneficiaries. Data illustrated simultaneous use of opioids and benzos influences overdose risk over time, specifically during the first 90 days of use.
“Patients who must be prescribed both an opioid and a benzodiazepine should be closely monitored by health care professionals due to an increased risk for overdose, particularly in the early days of this medication regimen,” said Inmaculada Hernandez, PharmD, PhD, an assistant professor at the University of Pittsburgh School of Pharmacy, in a press release.
More artilces on opioids:
Sculptor places 700-pound heroin spoon outside Purdue Pharma headquarters
Schumacher Clinical Partners addresses opioid epidemic
Viewpoint: Opioid treatment calls for more than just new drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
